XML 123 R112.htm IDEA: XBRL DOCUMENT v3.25.0.1
Restructuring and Asset Impairments - Additional information (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges $ 24,700,000 $ 22,300,000 $ 4,800,000
Severance payment 24,200,000 13,100,000 7,800,000
Impairment charge against operating lease right of use assets 1,500,000 3,200,000  
Scrapped Inventories 4,700,000    
BBIO, Nano and CALID Segments [Member] | R&D [Member]      
Restructuring Cost and Reserve [Line Items]      
Impairment charge 400,000    
Bruker Cellular Analytics [Member]      
Restructuring Cost and Reserve [Line Items]      
Impairment charge of various equipment 0 2,300,000  
Employee Severance [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 13,100,000 20,500,000 2,400,000
Severance payment 17,800,000 12,300,000 $ 5,400,000
Employee Severance [Member] | BBIO, Nano and CALID Segments [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 4,600,000    
Severance payment 3,400,000    
Employee Severance [Member] | Bruker Cellular Analytics [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 9,000,000 14,900,000  
Severance payment $ 15,100,000 $ 9,800,000